The objective of this study was to estimate the cost effectiveness of imatinib mesylate in the treatment of GIST. Methods: A cost-effectiveness model of GIST treatment was developed. Long- term ...

The cost effectiveness of imatinib mesylate was estimated by extrapolating long-term survival and costs from the pivotal multicentre trial of 147 patients with advanced GIST receiving imatinib ...

Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

The US Food and Drug Administration (FDA) has approved Imkeldi (imatinib) oral solution, the first oral liquid form of ...